Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Acta Endocrinologica|October 1, 1987
Macroprolactinomas and functionless pituitary tumours. Immunostaining and effect of dopamine agonist therapyR W Gasser, E Mueller-Holzner, F Skrabal, et al.
The American Journal of Psychiatry|December 31, 2004
Osteoporosis in patients with schizophreniaMartina Hummer, Peter Malik, Rudolf W Gasser, et al.
Clinical Endocrinology|January 1, 1985
Multiple intracranial metastases from a prolactin secreting pituitary tumourR W Gasser, G Finkenstedt, F Skrabal, et al.
Neuroscience|December 1, 1994
Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluidR Kirchmair, A Benzer, J Troger, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patientsR Ischia, R W Gasser, R Fischer-Colbrie, et al.
The Journal of Urology|March 29, 2000
Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostateR Ischia, A Hobisch, R Bauer, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 13, 2013
How long should women with postmenopausal osteoporosis be treated with a bisphosphonate?K Kerschan-Schindl, J Haschka, B Obermayer-Pietsch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 20, 2014
Current controversies in clinical management of postmenopausal osteoporosisK Kerschan-Schindl, P Mikosch, B Obermayer-Pietsch, et al.
Pageof 6